Business Standard

Wednesday, January 08, 2025 | 03:04 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Malaria drug Trump used to prevent Covid-19 found ineffective in major test

Hydroxychloroquine did not seem to cause serious harm but was no better than placebo pills, says medical journal.

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
Premium

Marilynn Marchione | AP
A malaria drug US President Donald Trump took to try to prevent Covid-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though—about 40 per cent on it had side effects, mostly mild stomach problems.

“We were disappointed. We would have liked for this to work,” said the study leader Dr David Boulware, an infectious

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in